Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Document › Details

Miltenyi Biotec GmbH. (10/12/18). "Press Release: Miltenyi Biotec Acquires Microscopy Specialist LaVision BioTec". Bergisch Gladbach & Bielefeld.

Organisation Organisation LaVision BioTec GmbH
  Group Miltenyi Biotec (Group)
Products Product TriMScope microscopy platform
  Product 2 cell analysis technology
Index term Index term LaVision BioTec–Miltenyi Biotec: investment, 201810 acquisition of LaVision BioTec GmbH by Miltenyi
Persons Person Miltenyi, Stefan (Miltenyi Biotec 201404 Founder + President)
  Person 2 Spiecker, Heinrich (LaVision BioTec GmbH 201810 Managing Director)

Miltenyi Biotec strengthens its portfolios for cell analysis and preclinical imaging by acquiring premium expertise in microscopy.

Miltenyi Biotec GmbH, a global provider of products and services for advancing biomedical research and cellular therapy, announced today that it has acquired the high-end microscopy specialist LaVision BioTec GmbH.

Located in Bielefeld, Germany, LaVision BioTec is a leading global specialist for advanced light-sheet and multiphoton microscopy solutions for life science applications. Since its foundation in 2000, LaVision BioTec has developed innovative products that successfully address the high-end microscopy market for applications in neuroscience, oncology, immunology, and developmental biology. TriM Scope is the company’s modular multiphoton and confocal microscopy platform that combines single- and multi-beam operation and enables simultaneous real-time and deep in vivo imaging. With its UltraMicroscopes, LaVision BioTec launched the first commercial light-sheet microscopes, allowing imaging of large cleared tissue samples.

“We are very happy to welcome our new colleagues from LaVision BioTec to our organization”, says Stefan Miltenyi, founder of Miltenyi Biotec. “By combining our expertise in cell analysis and innovative detection reagents with LaVision BioTec’s imaging know-how, we will develop pioneering analytical tools for biomedical research.”

“Our mission has always been to develop and market new technologies such as multiphoton-microscopy and light-sheet microscopy”, explains Dr. Heinrich Spiecker, Managing Director of LaVision BioTec. “By joining Miltenyi Biotec we have fused with a partner that will drive our business forward and increase the range of applications for our systems.”

LaVision BioTec will become part of the Miltenyi Biotec family, and will continue operating from their headquarters in Bielefeld. Miltenyi Biotec will market LaVision BioTec’s products.

Miltenyi Biotec Media Contact

Holger Buelow
+49 2204 8306-6680

About Miltenyi Biotec:

Miltenyi Biotec is a global provider of products and services that advance biomedica research and cellular therapy. from basic and translational research to clinical application. With 2,500 employees in 28 countries Miltenyi Biotec is dedicated advancing biomedical sciences and developing novel therapies for unmet clinical needs.

About LaVision BioTec:

LaVision BioTec GmbH develops and manufactures advanced microscopy solutions for the life sciences. All departments from development to production are located in the headquarters in Bielefeld. LaVision BioTec serves the global market by addressing researchers in academia and industry.

Record changed: 2018-11-03


Picture [iito] Plain Stupid Simple 650x80px

More documents for Miltenyi Biotec (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top